| |
| |
|
| Insider
Information: |
Hyde Joseph R III |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,411,298 |
|
|
Indirect Shares
|
2,672,247 |
|
|
| Direct
Value |
$234,205,948 |
|
|
|
Indirect Value
|
$6,454,707 |
|
|
| Total
Shares |
7,083,545 |
|
|
| Total
Value |
$240,660,655 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fedex Corp |
FDX |
Director |
2009-04-29 |
132,000 |
2008-11-03 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director, 10% Owner |
2019-01-02 |
4,207,368 |
2019-01-02 |
2,670,247 |
Premium* |
|
|
Autozone Inc |
AZO |
Director |
2018-01-01 |
71,930 |
2018-01-01 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2005-10-11 |
4 |
B |
$7.80 |
$5,850,000 |
D/D |
750,000 |
8,756,855 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-11-01 |
4 |
B |
$2.80 |
$9,150,000 |
D/D |
3,267,857 |
8,851,497 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-01-01 |
4 |
A |
$4.20 |
$16,375 |
D/D |
3,899 |
9,132,861 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-10-01 |
4 |
A |
$3.35 |
$8,250 |
D/D |
2,463 |
9,298,913 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-04-01 |
4 |
A |
$4.04 |
$13,625 |
D/D |
3,373 |
9,405,014 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2012-07-01 |
4 |
A |
$3.52 |
$8,250 |
D/D |
2,344 |
9,581,736 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-07-01 |
4 |
A |
$6.62 |
$13,625 |
D/D |
2,058 |
9,590,371 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-01-01 |
4 |
A |
$2.65 |
$9,750 |
D/D |
3,679 |
9,731,380 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-04-01 |
4 |
A |
$2.57 |
$9,000 |
D/D |
3,502 |
9,734,882 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2012-10-01 |
4 |
A |
$4.58 |
$8,250 |
D/D |
1,801 |
9,957,410 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-06-28 |
4 |
B |
$4.75 |
$4,631,250 |
D/D |
975,000 |
10,709,882 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-10-01 |
4 |
A |
$1.87 |
$13,625 |
D/D |
7,286 |
10,723,785 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-07-01 |
4 |
A |
$4.79 |
$8,250 |
D/D |
1,722 |
10,941,802 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-01-02 |
4 |
A |
$1.68 |
$13,625 |
D/D |
8,110 |
11,577,156 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,664 |
14,834,206 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-03-06 |
4 |
B |
$0.00 |
$0 |
D/D |
5,988,024 |
18,197,005 |
3.84 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-04-01 |
4 |
A |
$1.56 |
$13,625 |
D/D |
8,734 |
18,205,739 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-07-01 |
4 |
A |
$1.39 |
$13,625 |
D/D |
9,802 |
18,215,542 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2015-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,685 |
28,183,805 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2015-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
29,275,977 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
22,007 |
29,297,984 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2016-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,902 |
29,325,856 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,409 |
33,354,225 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2016-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,559 |
35,474,960 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
24,545,455 |
39,379,661 |
0 |
- |
|
178 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
